ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,970Medicare Part D Prescriptions Filled, Including Refills

Rank: 249 out of 1111

$416K Total Retail Price of All Prescriptions

Rank: 305 out of 1111

304 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 304 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 304 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 6,551 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LEVOTHYROXINE SODIUM 329 266 1 3
HYDROCODONE-ACETAMINOPHEN 283 170 S3 2 1
FUROSEMIDE 280 247 3 6
POTASSIUM CHLORIDE 275 237 4 9
LISINOPRIL 230 195 5 2
OMEPRAZOLE 221 165 6 4
SIMVASTATIN 193 171 7 5
METFORMIN HCL 151 134 8 8
AMLODIPINE BESYLATE 149 124 9 7
ALENDRONATE SODIUM 130 123 10 35
HYDROCHLOROTHIAZIDE 128 123 11 11
ATORVASTATIN CALCIUM 118 106 12 15
ATENOLOL 111 96 13 22
PAROXETINE HCL 109 108 14 55
SERTRALINE HCL 93 79 15 24
NAMENDA 92 80 16 31
LYRICA 86 72 17 62
AZITHROMYCIN 80 56 18 39
GABAPENTIN 79 64 19 10
ZOLPIDEM TARTRATE 77 43 20 16
POLYETHYLENE GLYCOL 3350 74 61 21 45
ROPINIROLE HCL 73 65 22 68
WARFARIN SODIUM 73 71 22 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 52 24 23
MELOXICAM 70 54 25 18
METOPROLOL SUCCINATE 70 61 25 20
RANITIDINE HCL 66 61 27 29
TORSEMIDE 65 46 28 118
DIOVAN 64 57 29 51
DONEPEZIL HCL 63 63 30 25
QUINAPRIL HCL 62 62 31 213
NEXIUM 62 60 31 26
TRAMADOL HCL 55 48 33 13
DOXAZOSIN MESYLATE 54 44 34 87
BUSPIRONE HCL 53 35 35 96
ULORIC 53 53 35 408
DICLOFENAC SODIUM 52 47 37 108
ALLOPURINOL 51 36 38 36
AMLODIPINE BESYLATE-BENAZEPRIL 50 50 39 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.